成为第一个知道
获取有关突发新闻、现场活动和独家报道的浏览器通知。
美国食品和药物管理局周二拒绝批准 Neffy,这是一种肾上腺素鼻喷雾剂,为治疗严重过敏反应提供了无针替代方案。 FDA 表示 Neffy 需要更多研究。
成为第一个知道
获取有关突发新闻、现场活动和独家报道的浏览器通知。
Breaking News
FigureAsia (ISSN: 3005-3978) is a premier international magazine dedicated to in-depth coverage of Asia. It offers authoritative analysis and reportage across critical domains, including politics, economics, society, culture, and technology. FigureAsia serves as a distinguished platform, delivering nuanced insights and comprehensive perspectives to an informed Asian readership, with a focus on both regional dynamics and global trends.
© 2024 FigureAsia Publishing Group Limited All Rights Reserved.
Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information | Ad Choices
FigureAsia may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
ISSN: 3005-3978 is the property of FigureAsia. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.